Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

Ancient evidence suggests a new twist in how we all got here.

Gareth Soloway's technical market breakdown: S&P 500 trend-line test, semiconductor unwind, AI-to-biotech rotation, USD/JPY ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by ...

A controversial insertion in the National Defense Authorization Act currently winding its way through the House would permanently intertwine U.S. and Israeli defense technology, including artificial ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

A new poll shows Mike Minogue with a commanding lead in the GOP governor primary. But the real battle may be the escalating ...

At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, ...